a company called Novo Nordisk has been doing really well lately. Some people have been buying options, which are like little bets, to predict how the company's stock price will go up or down. Some people think the company's stock price will go up, while others think it might go down. Everyone is trying to guess what will happen, and they're all buying different little bets. This article is talking about all those little bets that people have been buying and what it might mean for the company. Read from source...

1. The article tends to provide only one side of the story - bullish on Novo Nordisk, and doesn't offer an alternative bearish perspective.
2. The options trading patterns highlighted seem selective and not comprehensive. Why were only 11 unusual trades spotted, instead of taking into account all trades?
3. The prices presented for projected price targets ($70.0 to 140.0) seem to be arbitrary and with no underlying explanation or justification.
4. The explanation for options trading and the significance of volume and open interest seems generic and not specific to Novo Nordisk.
5. The options traders' risks and methods to manage risks are briefly mentioned and not explained in depth.
6. The information about Novo Nordisk is quite basic and lacks specific details about the company's performance.
7. The statement 'Novo Nordisk is the leading provider of diabetes-care products in the world' seems to be an exaggeration and a gross generalization.
8. The mention of biopharmaceutical segment's specialization in protein therapies for disorders like hemophilia is misleading as this segment constitutes only around 10% of the company's revenue.
9. The new price target of $160 given by Cantor Fitzgerald seems unusually high without any justifiable analysis.
10. The use of technical jargon and complex terminologies make the article difficult to understand, especially for non-experts.

Novo Nordisk (NVO) has a surge in options activity, with the majority of traders being bullish. Projected price targets range from $70.0 to $140.0 over the next three months. This data should be taken into account when investing in NVO, as it can indicate the overall sentiment towards the stock and potential future price movement. However, options trading activity is risky and may not be suitable for all investors. Please consult with a financial advisor before making any investment decisions.